Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.

Groenendijk, Floris H; Fransen van de Putte, Elisabeth E; van Rhijn, Bas W G; Bernards, René; van der Heijden, Michiel S

Groenendijk, Floris H; Fransen van de Putte, Elisabeth E; van Rhijn, Bas W G; Bernards, René; van der Heijden, Michiel S.

Afiliação

Groenendijk FH; Netherlands Cancer Institute, Amsterdam, The Netherlands.
Fransen van de Putte EE; Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Rhijn BW; Netherlands Cancer Institute, Amsterdam, The Netherlands.
Bernards R; Netherlands Cancer Institute, Amsterdam, The Netherlands.
van der Heijden MS; Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: ms.vd.heijden@nki.nl.

Eur Urol ; 68(2): e33-4, 2015 Aug.

Article em En | MEDLINE | ID: mdl-25776733

Assuntos

Terapia Neoadjuvante; Neoplasias da Bexiga Urinária; Humanos; Mutação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article